ESPRIT registry nine-year interim real-world safety, effectiveness, and patient-reported outcomes of adalimumab for moderate to severe psoriasis
2019 ◽
Vol 81
(4)
◽
pp. AB206
Keyword(s):
2020 ◽
Vol 83
(6)
◽
pp. AB17
Keyword(s):
Keyword(s):
2020 ◽
Vol 28
(10)
◽
pp. 4933-4942
◽
2013 ◽
Vol 28
(2)
◽
pp. 192-203
◽
2021 ◽
2017 ◽
Vol 76
(6)
◽
pp. AB102
Keyword(s):
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 551.2-551